Erratum: Loss of p63 and its microRNA-205 target results in enhanced cell migration and metastasis in prostate cancer (Proceedings of the National Academy of Sciences of the United States of America (2012) 109 (15312-15317) DOI: 10.1073/pnas.1110977109);Loss of p63 and its microRNA-205 target results in enhanced cell migration and metastasis in prostate cancer

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 38, 2012, Pages 15312-15317

  Tucci, Paola ^a,b   Agostini, Massimiliano ^a   Grespi, Francesca ^a,c,d   Markert, Elke K ^e   Terrinoni, Alessandro ^f   Vousden, Karen H ^g   Muller, Patricia A J ^g   Dötsch, Volker ^h   Kehrloesser, Sebastian ^h   Sayan, Berna S ⁱ   Giaccone, Giuseppe ^j   Lowe, Scott W ^k   Takahashi, Nozomi ^c,d   Vandenabeele, Peter ^c,d   Knight, Richard A ^a   Levine, Arnold J ^e   Melino, Gerry ^a,c,f  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b UNIVERSITY OF CALABRIA   (Italy)

^c DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^d GHENT UNIVERSITY   (Belgium)

^e INSTITUTE FOR ADVANCED STUDY   (United States)

^f UNIVERSITY OF ROME TOR VERGATA   (Italy)

^g BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

^h GOETHE UNIVERSITY   (Germany)

ⁱ UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^j NATIONAL CANCER INSTITUTE   (United States)

^k MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

more..

Author keywords

Apoptosis; DU145 cell; E cadherin; PC3 cell; Tumorigenesis

Indexed keywords

CELL MARKER; MICRORNA 205; MUTANT PROTEIN; PROTEIN P53; PROTEIN P63; VIMENTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER INFILTRATION; CANCER INHIBITION; CANCER PROGNOSIS; CELL MIGRATION; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION; GENE SILENCING; GENE TARGETING; GLEASON SCORE; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; MOUSE; NONHUMAN; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN TARGETING;

EID: 84866546174     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1324223111     Document Type: Erratum

References (27)

1. Yang A, et al. (1998) p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell 2: 305-316. (Pubitemid 128379271)
2. Levine AJ, Tomasini R, McKeon FD, Mak TW, Melino G (2011) The p53 family: Guardians of maternal reproduction. Nat Rev Mol Cell Biol 12:259-265.
3. Melino G (2011) p63 is a suppressor of tumorigenesis and metastasis interacting with mutant p53. Cell Death Differ 18:1487-1499.
4. Antonini D, et al. (2010) Transcriptional repression of miR-34 family contributes to p63-mediated cell cycle progression in epidermal cells. J Invest Dermatol 130: 1249-1257.
5. Rivetti di Val Cervo P, et al. (2012) p63-microRNA feedback in keratinocyte senescence. Proc Natl Acad Sci USA 109:1133-1138.
6. Gregory PA, Bracken CP, Bert AG, Goodall GJ (2008) MicroRNAs as regulators of epithelial-mesenchymal transition. Cell Cycle 7:3112-3118.
7. Gregory PA, et al. (2008) The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 10:593-601. (Pubitemid 351627379)
8. Baffa R, et al. (2009) MicroRNA expression profiling of human metastatic cancers identifi es cancer gene targets. J Pathol 219:214-221.
9. Wu H, Zhu S, Mo YY (2009) Suppression of cell growth and invasion by miR-205 in breast cancer. Cell Res 19:439-448.
10. Coppola V, De Maria R, Bonci D (2010) MicroRNAs and prostate cancer. Endocr Relat Cancer 17:F1-F17.
11. Majid S, et al. (2010) MicroRNA-205-directed transcriptional activation of tumor suppressor genes in prostate cancer. Cancer 116:5637-5649.
12. Gandellini P, et al. (2009) miR-205 Exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase Cepsilon. Cancer Res 69: 2287-2295.
13. Graham TR, et al. (2008) Insulin-like growth factor-I-dependent up-regulation of ZEB1 drives epithelial-to-mesenchymal transition in human prostate cancer cells. Cancer Res 68:2479-2488. (Pubitemid 351521824)
14. Kupfer A, Louvard D, Singer SJ (1982) Polarization of the Golgi apparatus and the microtubule-organizing center in cultured fibroblasts at the edge of an experimental wound. Proc Natl Acad Sci USA 79:2603-2607. (Pubitemid 12068407)
15. Adorno M, et al. (2009) A Mutant-p53/Smad complex opposes p63 to empower TGFbeta-induced metastasis. Cell 137:87-98.
16. Muller PAJ, et al. (2009) Mutant p53 drives invasion by promoting integrin recycling. Cell 139:1327-1341.
17. Lang GA, et al. (2004) Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome. Cell 119:861- 872.
18. Flores ER, et al. (2005) Tumor predisposition in mice mutant for p63 and p73: Evidence for broader tumor suppressor functions for the p53 family. Cancer Cell 7:363-373. (Pubitemid 40544653)
19. Muller PA, et al. (2012) Mutant p53 enhances MET trafficking and signalling to drive cell scattering and invasion. Oncogene, 10.1038/onc.2012. 148.
20. Taylor BS, et al. (2010) Integrative genomic profiling of human prostate cancer. Cancer Cell 18:11-22.
21. Sboner A, et al. (2010) Molecular sampling of prostate cancer: A dilemma for predicting disease progression. BMC Med Genomics 16:3-8.
22. Chiang CT, Chu WK, Chow SE, Chen JK (2009) Overexpression of delta Np63 in a human nasopharyngeal carcinoma cell line downregulates CKIs and enhances cell proliferation. J Cell Physiol 219:117-122.
23. Su X, et al. (2010) TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs. Nature 467:986-990.
24. Song H, Bu G (2009) MicroRNA-205 inhibits tumor cell migration through downregulating the expression of the LDL receptor-related protein 1. Biochem Biophys Res Commun 388:400-405.
25. Strano S, et al. (2002) Physical interaction with human tumor-derived p53 mutants inhibits p63 activities. J Biol Chem 277:18817-18826. (Pubitemid 34952441)
26. Gaiddon C, Lokshin M, Ahn J, Zhang T, Prives C (2001) A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain. Mol Cell Biol 21:1874-1887. (Pubitemid 32156407)
27. Sarrió D, et al. (2008) Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. Cancer Res 68:989-997. (Pubitemid 351272216)